Technical Analysis for KOD - Kodiak Sciences Inc

Grade Last Price % Change Price Change
D 112.27 -2.28% -2.62
KOD closed down 2.28 percent on Monday, April 19, 2021, on 45 percent of normal volume.
Earnings due: May 10
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical KOD trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Spinning Top Other 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
20 DMA Support Bullish -2.28%
Crossed Above 20 DMA Bullish -2.97%
Up 3 Days in a Row Strength -2.97%
20 DMA Resistance Bearish -2.95%
Shooting Star Candlestick Bearish -2.95%
Pocket Pivot Bullish Swing Setup -2.95%
Older End-of-Day Signals for KOD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support about 16 hours ago
60 Minute Opening Range Breakdown about 16 hours ago
Down 3% about 16 hours ago
Fell Below 10 DMA about 16 hours ago
Up 1% about 17 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Kodiak Sciences Inc Description

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat retinal diseases. The company's lead product candidate is KSI-301, a vascular endothelial growth factor (VEGF)-biological agent that is in Phase 1b clinical study to treat wet age-related macular degeneration (AMD) and diabetic retinopathy. Its preclinical stage product candidate include KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate to target inflammation and abnormal angiogenesis in the pathogenesis of retinal vascular diseases. The company's early research pipeline include KSI-601, a triplet inhibitor for dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was founded in 2009 and is headquartered in Palo Alto, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Inflammation Macular Degeneration Ophthalmology Related Macular Degeneration Retina Vascular Diseases Diabetic Retinopathy Wet Age Related Macular Degeneration Retinopathy Preclinical Stage Product Angiology Retinal Disease Angiogenesis Retinal Diseases Vascular Endothelial Growth Factor

Is KOD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 171.05
52 Week Low 42.97
Average Volume 304,075
200-Day Moving Average 99.83
50-Day Moving Average 125.73
20-Day Moving Average 113.94
10-Day Moving Average 111.50
Average True Range 7.68
ADX 16.72
+DI 18.05
-DI 20.22
Chandelier Exit (Long, 3 ATRs ) 114.00
Chandelier Exit (Short, 3 ATRs ) 126.67
Upper Bollinger Band 124.72
Lower Bollinger Band 103.16
Percent B (%b) 0.42
BandWidth 18.92
MACD Line -3.48
MACD Signal Line -4.47
MACD Histogram 0.991
Fundamentals Value
Market Cap 5.7 Billion
Num Shares 50.8 Million
EPS -1.50
Price-to-Earnings (P/E) Ratio -75.10
Price-to-Sales 0.00
Price-to-Book 22.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 121.32
Resistance 3 (R3) 121.56 118.80 119.81
Resistance 2 (R2) 118.80 116.49 118.67 119.30
Resistance 1 (R1) 115.53 115.07 114.15 115.29 118.80
Pivot Point 112.77 112.77 112.08 112.64 112.77
Support 1 (S1) 109.50 110.46 108.12 109.26 105.74
Support 2 (S2) 106.74 109.04 106.61 105.24
Support 3 (S3) 103.47 106.74 104.73
Support 4 (S4) 103.23